PatrickJLoehrerSr.MD

Oncology • Indianapolis, IN

Gastrointestinal Cancer, Hematologic Oncology

Professor, Oncology, Indiana University School of Medicine

Join to view full profile

Dr. Loehrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Loehrer's full profile

Already have an account?

Office
535 Barnhill Dr
Rt 448
Indianapolis, IN 46202
Phone+1 317-278-7418
Is this information wrong?

Summary

I am a board certified medical oncologist specializing in Gastrointestinal and thymic malignancies. I also am involved with global oncology

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
Rush University Medical CenterResidency, Internal Medicine, 1978 - 1980
Rush Medical College of Rush University Medical CenterClass of 1978

Certifications & Licensure

IN State Medical License 1981 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Indianapolis Monthly Castle Connolly, 2010-2011, 2013
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Start of enrollment: 1994 Sep 01
Completed
Phase 3
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer Start of enrollment: 1999 Feb 01
Completed
Phase 2
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma Start of enrollment: 2001 Jun 19
Completed
Phase 2
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Start of enrollment: 2003 Aug 29
Completed
Phase 3
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma Start of enrollment: 2005 Jan 01
Completed
Phase 2
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma Start of enrollment: 2006 Apr 01
Completed
Phase 1
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Start of enrollment: 2007 Feb 28
Completed
Phase 2
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer Start of enrollment: 2008 Jun 01
Terminated
Phase 2
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps Start of enrollment: 2009 Jan 01
Completed
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies Start of enrollment: 2011 Jun 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas Start of enrollment: 2014 Oct 01
Completed
Phase 2
Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2017 Oct 13
Terminated
Phase 2
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women Start of enrollment: 2021 Nov 18
Recruiting
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) Start of enrollment: 2019 Sep 11
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO.
Maria T Bourlon, Ami S Bhatt, Gilberto Lopes, Fredrick Chite Asirwa, Alexandru E Eniu, Lawrence N Shulman, Julia Close, Jamie Von Roenn, Michal Tibbits, Doug Pyle, Pat...> ;JCO Global Oncology. 2024 Apr 1
Expanding Myeloma Training and Care in Western Kenya Through the ECHO Model: The Pilot Phase.
Mercy Atieno Oduor, Teresa Cherop Lotodo, Tyler Severance, Beatrice Jepngetich Melly, Austin Omondi, Indagala Ndenga, Diana Flora Namaemba, Yvette Oyollo, Kelvin Moges...> ;JCO Global Oncology. 2024 Apr 1
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
Aristine Cheng, Anuj Kashyap, Helene Salvator, Lindsey B Rosen, Devon Colby, Fatemeh Ardeshir-Larijani, Patrick J Loehrer, Li Ding, Saul O Lugo Reyes, Sean Riminton, M...> ;The New England Journal of Medicine. 2024 Mar 21
Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report.
Fatemeh Ardeshir-Larijani, Rohan Maniar, Subir Goyal, Patrick J Loehrer, Tieying Hou, Victoria DeBrock, Hector Mesa> ;Clinical Lung Cancer. 2024 Mar 1
Uptake and Outcomes of a Clinical Breast Exam Program in Western Kenya.
Bhatia, M., Muema, N., Kiptoo, S., Limenik, I., Adaniya, E., Kibiwot, S., Wabende, L., Jepkirui, S., Awuor, D., Morgan, J., Busakhala, N., Loehrer, P., Hunter-Squires, J.> ;Annals of Surgical Oncology. 2024 Feb 1
Breast Health Awareness: Understanding Health-Seeking Behavior in Western Kenya.
Bhatia, M., Kisilu, N., Kiptoo, S., Limenik, I., Adaniya, E., Kibiwot, S., Wabende, L., Jepkirui, S., Awuor, D., Morgan, J., Busakhala, N., Loehrer, P., Hunter-Squires...> ;Annals of Surgical Oncology. 2024 Feb 1
1 citations
Global oncology research and training at US National Cancer Institute-designated cancer centres: results of the 2021 Global Oncology Survey.
Elise M Garton, Mishka K Cira, Patrick J Loehrer, Linsey Eldridge, Allison Frank, Laura Prakash, Shine Chang, Ramzi G Salloum, Henry Ciolino, Min He, Kalina Duncan, Go...> ;The Lancet. Oncology. 2023 Oct 1
Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.
Yan Tong, Philip Tonui, Omenge Orang'o, Jianjun Zhang, Titus Maina, Kapten Muthoka, John Groopman, Joshua Smith, Erin Madeen, Aaron Ermel, Patrick Loehrer, Darron R Brown> ;BMC Infectious Diseases. 2023 Jun 6
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
Walid L Shaib, Rupji Manali, Yuan Liu, Bassel El-Rayes, Patrick Loehrer, Bert O'Neil, Steven Cohen, Tina Khair, Erwin Robin, Timothy Huyck, Tanios Bekaii-Saab> ;European Journal of Cancer. 2023 Aug 1
4 citations
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, Huda Salman, Patrick J Loehrer> ;JCO Precision Oncology. 2023 Feb 1
Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study.
Yan Tong, Philip Tonui, Omenge Orang'o, Jianjun Zhang, Titus Maina, Kapten Muthoka, John Groopman, Joshua Smith, Erin Madeen, Aaron Ermel, Patrick Loehrer, Darron Brown> ;Research Square. 2023 Jan 27
Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescencehybridisation testing forand thetranslocat...
Gail H Vance, Teresa Lotodo, Nicholas Kigen, Ryan Stohler, Haki Choi, Festus Njuguna, Ann M Moormann, Erastus Kirwa, Sandra Langat, Patrick Loehrer, Terry Vik> ;Ecancermedicalscience. 2023 Jan 1
Thymoma With Triple Threat: Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and T-Cell Large Granular Lymphocytic Leukemia.
Tara Seibert, Patrick J Loehrer, Andrew R W O'Brien> ;Journal of Hematology. 2022 Dec 1
9 citations
Acceptance and commitment therapy for patient fatigue interference and caregiver burden in advanced gastrointestinal cancer: Results of a pilot randomized trial.
Catherine E Mosher, Ekin Secinti, Wei Wu, Deborah A Kashy, Kurt Kroenke, Jonathan B Bricker, Paul R Helft, Anita A Turk, Patrick J Loehrer, Amikar Sehdev, Ahmad A Al-H...> ;Palliative Medicine. 2022 Jul 1
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Cristina Mullenix, Madison Ballman, Haobin Chen, Shannon Swift, Meredith J McAdams, Yo-Ting Tsai, Renee N Donahue, Trina Poretta, Sarthak Gupta, Patrick J Loehrer, Jef...> ;The Oncologist. 2022 Apr 5
Strategies to Increase Participation of African Populations in Clinical Trials.
Patrick J Loehrer, John Carpten, Delva Shamley, Gopal, S.> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
5 citations
A phase II study of buparlisib in relapsed or refractory thymomas.
Mohammad I Abu Zaid, Milan Radovich, Sandra Althouse, Hao Liu, Aaron J Spittler, Jeffrey Solzak, Sunil Badve, Patrick J Loehrer Sr> ;Frontiers in Oncology. 2022 Jan 1
6 citations
Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV.
Aaron Ermel, Yan Tong, Phillip Tonui, Omenge Orang’o, Kapten Muthoka, Nelson Wong, Titus Manai, Stephen Kiptoo, Patrick J. Loehrer, Darron R. Brown> ;International Journal of STD & AIDS. 2021 Jul 7
2 citations
Thymic Carcinomas and Second Malignancies: A Single-Center Review.
Sunil Badve, Rachel E. Dougherty, Michael Balatico, Kenneth A. Kesler, Patrick J. Loehrer, Yesim Gökmen-Polar> ;Cancers. 2021 May 19
4 citations
Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial.
Catherine E. Mosher, Ekin Secinti, Kurt Kroenke, Paul R. Helft, Anita Ahmed Turk, Patrick J. Loehrer, Amikar Sehdev, Ahmad Al-Hader, Victoria L. Champion, Shelley A. J...> ;Pilot and Feasibility Studies. 2021 Apr 20
3 citations
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence.
Ryan Nguyen, Laura B. Vater, Lava Timsina, Greg Andrew Durm, Katelin Rupp, Keylee Wright, Miranda H. Spitznagle, Brandy Paul, Shadia I. Jalal, Lisa Carter-Harris, Kare...> ;Plos One. 2021 Apr 16
1 citations
Status of Cancer Care at Network Sites of the Nation's Academic Cancer Centers.
Stanton L. Gerson, Kate Shaw, Louis B. Harrison, Randall F. Holcombe, Laura F. Hutchins, Carrie B. Lee, Patrick J. Loehrer, Daniel Mulkerin, W. Thomas Purcell, Lois Te...> ;Journal of the National Comprehensive Cancer Network. 2021 Mar 11
3 citations
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya.
Mercy A Oduor, Teresa C Lotodo, Terry A. Vik, Kelvin M Manyega, Patrick J. Loehrer, Austin A Omondi, John O Oguda, Fredrick Chite Asirwa> ;JCO Global Oncology. 2021 Mar 1
3 citations
Retrospective Analysis of Presentation, Treatment, and Outcomes of Multiple Myeloma at a Large Public Referral Hospital in Eldoret, Kenya.
Kelvin M Manyega, Teresa C Lotodo, Mercy A Oduor, Diana F Namaemba, Austin A Omondi, Yvette L Oyolo, John O Oguda, Patrick J. Loehrer, Terry A Vik, Fredrick Chite Asirwa> ;JCO Global Oncology. 2021 Mar 1
3 citations
Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure
Elkanah Omenge Orang'o, Jordan P. Emont, Aaron Ermel, Tao Liu, Victor Omodi, Yan Tong, Peter Itsura, Philip Tonui, Titus Maina, John M. Ong’echa, Kapten Muthoka, Steph...> ;International Journal of Gynaecology and Obstetrics. 2020 Nov 1
Join now to see all

Press Mentions

Empowering People with Cancer: A Q&A with Cancer.Net Editor in Chief Dr. Jyoti PatelJune 8th, 2021
Once-Trumpeted $150M Simon Cancer Center to Be Empty by 2026September 12th, 2020
Indiana University School of Medicine Researchers Use Cutting-Edge Technology to Predict Which Triple Negative Breast Cancer Patients May Avoid Recurrence and Those Who Are at High-Risk of RelapseDecember 16th, 2019
Join now to see all

Grant Support

Eastern Cooperative Oncology GroupNational Cancer Institute1994–2012
Indiana University Melvin And Bren Simon Cancer Center Support GrantNational Cancer Institute2008–2011
Usa/Japan--Oral Uracil/Ftorafur+ Leucovorin In ColorectaNational Center For Research Resources2000–2002
Perillyl Alcohol In Resectable Pancreatic CancerNational Center For Research Resources2000–2002
LY231514 (Thymidylate Synthase Inhibitor) With Pancreatic CancerNational Center For Research Resources1996–1997